Clinical Trial

Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams

Study acronym: AD-CAP
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this study is to compare effectiveness and safety of Azithromycin versus Doxycycline in adult patients hospitalized with community acquired pneumonia (CAP) treated with Beta-lactams.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-05; most recent amendment 2026-07-01.
Status change: Not Yet Recruiting → Recruiting 2025-10-06
Trial Details
NCT Number NCT07164131
Lead Sponsor Mayo Clinic
Conditions Community-acquired Pneumonia
Enrollment 1,120 participants
Start Date 2025-09-15
Primary Completion 2030-09-01 (estimated)
Study Completion 2031-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-02